Failed IVF: Decoding What Your Doctor Says Next

A failed IVF cycle is not a small thing. You and your partner have given this round of treatment money, time off work, daily injections, monitoring, the retrieval, the wait, and possibly a transfer that did not implant. The cost is real, in every currency. Before we get into the data, I want to acknowledge what you have already put into this. The exhaustion you are feeling is not a character flaw. It is an accurate response to what just happened. And if you are sitting with the question of two failed IVF attempts what next, I want you to know that this conversation is the right next step, not a sign that you are giving up.

This post is for the reader who has had one or two failed IVF cycles and has a follow-up consult coming up. You already know what IVF is. You have lived through it. What follows is how to read the data your cycle generated, how to decode what your RE proposes next, and the questions worth bringing to the consult. If you are also sitting with grief that you have not been able to name out loud, please read the pillar post on what you are allowed to feel after a failed cycle before this one. The clinical work is easier when the grief is named first.

What a failed IVF cycle actually means

"Failed" can mean very different things in IVF, and each one points to a different next step. The first job of the post-cycle consult is to specify which one happened.

No eggs retrieved, or very few: this is a low responder cycle, often unexpected. The next conversation is about ovarian reserve, protocol type, and stimulation dose.

Eggs retrieved but no fertilization: roughly half of failed-fertilization cycles point to sperm or oocyte quality issues; some are unexplained. ICSI is the most common adjustment if conventional IVF was used.

Fertilization but no usable blastocysts: the embryo developmental block at the cleavage-to-blastocyst transition can point to oocyte quality, sperm quality, or laboratory conditions.

Euploid embryos available but no transfer pregnancy: this is the implantation failure category. Recurrent implantation failure, often defined as two to three failed transfers of good-quality embryos, is a distinct clinical entity with its own workup.²

A positive test that ended in chemical pregnancy or early loss: a different conversation, and one that often warrants the recurrent pregnancy loss workup if it has happened more than once.

The first thing I ask in a post-cycle review is: which of these happened in your cycle? The second is: what does that specific failure mode point to?

Before any of this, a number. Per-cycle live birth rates with IVF vary widely by age. The HFEA's UK data and the SART national report in the US show live birth rates around 40 percent per started cycle under age 35, around 20 percent at 38 to 40, and under 10 percent at 42 and above.⁴,⁵ Smith and colleagues' analysis of cumulative IVF live birth across multiple cycles showed that the cumulative rate keeps climbing through roughly three to six cycles before plateauing.¹ A single failed cycle, even at younger ages, is statistically common. Two is the threshold at which most clinics start asking whether the protocol needs to change. Three is the threshold at which the conversation about a different approach is usually warranted.

Reading the cycle data, metric by metric

This is the section I wish every failed-cycle patient walked into the consult with. The IVF cycle generates a paper trail, and each step has a metric that tells you something about whether the cycle did what was expected. The next plan should map directly to which step underperformed, not start from zero.

Antral follicle count plus AMH versus eggs retrieved: before the cycle, the antral follicle count from the baseline scan and the AMH level give a prediction of how many eggs you should retrieve. If you retrieved meaningfully fewer than predicted, that is a stimulation response issue. The conversations that follow include switching protocols (long agonist to antagonist, or vice versa), increasing FSH dose, adding LH, considering growth hormone adjuvant, or in some cases moving to a mini-IVF or dual-stim approach.

Eggs retrieved versus mature (MII): not every egg retrieved is mature enough to fertilise. A low maturation rate (under 60 percent) can point to trigger timing issues or to oocyte quality issues. Trigger timing is fixable. Oocyte quality is age-correlated and harder to change.

Fertilization rate: mature eggs that fertilise normally. Under 60 percent with conventional IVF may push the next cycle to ICSI. Under 50 percent with ICSI already in use flags sperm or egg quality, and may trigger a repeat semen analysis, advanced sperm testing, or a deeper conversation about oocyte factors.

Day 3 to day 5 development (blastulation rate): the proportion of fertilised embryos that reach the blastocyst stage by day five or six. Under 40 percent blastulation is on the low side and may flag embryo quality or laboratory conditions. The lab conditions question is one most patients do not know to ask. If your blastulation rate is much lower than the clinic's average, the conversation is worth having.

Euploid rate, if PGT-A was done: strongly age-correlated. Around 60 to 70 percent of embryos are euploid in patients under 35; under 30 percent at 40 and older. A surprisingly low euploid rate in a younger patient can be a signal worth investigating, though sample size at the individual cycle level is usually too small to draw firm conclusions.

Endometrial thickness and pattern at transfer: under 7 mm trilaminar at transfer is associated with lower implantation. ERA (endometrial receptivity array) testing is sometimes proposed for receptivity timing in recurrent implantation failure; the evidence is contested, and the most recent meta-analytic and RCT data have not shown clear benefit outside specific use cases.⁶

What I want from this list is not for you to memorise every metric. I want you to walk into the consult able to say: "Can we walk through each step of the cycle and tell me which ones were in expected range and which ones underperformed?" That single question changes the consult.

Decoding what your doctor proposes next

The next-cycle proposals fall into rough categories. Each one addresses a different problem. The honest framing is that some interventions are well-supported by evidence and some are widely offered without it.

Switch stimulation protocol: long agonist to antagonist, or antagonist to agonist, or addition of growth hormone or LH. Addresses egg yield and response. Evidence is strongest for the antagonist-versus-agonist choice; growth hormone benefit is debated and is reserved for specific low-responder categories.

Add ICSI or PICSI: addresses fertilization. ICSI is well-established for male factor infertility and prior fertilization failure. It does not improve outcomes in couples without a fertilization indication.

Move to PGT-A (preimplantation genetic testing for aneuploidy): addresses miscarriage rate and per-transfer implantation rate by selecting euploid embryos. The 2018 ASRM committee opinion on PGT-A⁷ and the 2019 STAR trial³ are nuanced: in good-prognosis younger patients, PGT-A does not clearly improve cumulative live birth per started cycle. It improves the per-transfer rate by concentrating euploid embryos into earlier transfers, but it does not change the underlying biology. In patients with recurrent loss or recurrent implantation failure, the evidence is more supportive.

Switch from fresh to frozen transfer: frozen single euploid transfer reduces OHSS risk and improves luteal-phase synchrony. It is now the default at many clinics for stimulated cycles where embryos can be banked. Not a universal solution but well-supported as a default.

ERA testing: endometrial receptivity array. The premise is that the implantation window can be individualised. The 2020 evidence review by Cozzolino and colleagues, and subsequent RCT data, have not shown a clear live-birth benefit in recurrent implantation failure populations.⁶ If your RE proposes it, ask what the expected benefit is in your specific case and what the evidence base is.

Immune workup, intralipids, steroids, IVIG: outside of specific autoimmune diagnoses (antiphospholipid syndrome, systemic lupus), the evidence for these adjuvants in IVF is weak to absent. The ESHRE good practice recommendations on recurrent implantation failure are explicit that immune therapies are not routine and should not be offered without an underlying diagnosis.²

Embryo glue, assisted hatching, sperm DNA fragmentation testing: selective use cases with mixed evidence. Worth asking what the proposed benefit is and what the evidence base looks like for your specific cycle profile.

Move to donor eggs or donor sperm: a different conversation, particularly relevant after multiple failed cycles in age-related decline. The changing direction post covers this in detail.

A break: also a legitimate next step. Sometimes the cycle should not be the next thing.

The way I read these proposals in clinic: each one should map to a specific problem that the cycle data identifies. "Try the same protocol with PGT-A" without a clear reason that PGT-A addresses your specific situation is not a plan. It is a sales pitch.

Two failed IVF attempts: what next

The two-failed-cycles question is a real threshold. Most ASRM-aligned and ESHRE-aligned guidance treats two failed cycles, particularly two failed euploid transfers, as the point at which the next conversation should be a strategy conversation, not a repeat.²

After two failed cycles, the questions to bring to the consult are different from after cycle one.

• Which step underperformed across both cycles? Is the pattern consistent?
• Is a workup for recurrent implantation failure indicated? (ESHRE recommends this typically after two to three failed transfers of good-quality embryos.²)
• Are there sperm DNA fragmentation tests, additional uterine imaging, or hysteroscopy procedures that have not been done?
• Is there a thrombophilia, thyroid, or autoimmune evaluation that should be considered, particularly if losses are part of the pattern?
• Is your current clinic the right clinic for your situation, or is a second opinion warranted?

The second opinion question is one most patients are reluctant to ask. A good RE will not be offended. They will often welcome it because a second perspective can break a stalemate. If your clinic offers the second opinion in-house with a different physician, that is also legitimate.

How many IVF cycles before changing approach

Most clinics will reassess seriously after two to three failed cycles or two to three failed euploid transfers. The cumulative live birth rate keeps climbing through roughly three to six cycles before plateauing, based on Smith and colleagues' analysis of national-scale data.¹ Age matters more than absolute cycle number for the cutoff conversation.

The financial and emotional ceiling is also allowed to be the deciding factor. There is no medical award for staying in treatment past your limits. The decision to stop, or to change paths, or to pause, is yours and your partner's. The RE's role is to give you accurate per-cycle estimates so that you can make the decision with eyes open.

I tell patients in clinic: name your stop point before you reach it. "We will do two more cycles, with X protocol change, and then revisit" is a real plan. "We will keep going until something works" is not a plan; it is a wish.

Failed IVF causes: the honest list

Search traffic to this post often comes from patients asking "why failed IVF" or "failed IVF causes." The honest list, in rough order of frequency:

• Embryo chromosomal abnormalities (aneuploidy): strongly age-correlated. The most common cause across all age groups.
• Embryo quality issues not detected by morphology alone: mitochondrial, metabolic, or epigenetic factors that current testing does not fully capture.
• Implantation failure with otherwise good embryos: often unexplained at the individual level. ESHRE estimates this represents around 10 percent of IVF couples after multiple cycles.²
• Endometrial or uterine factors: polyps, fibroids, scarring, adenomyosis, hydrosalpinx.
• Sperm quality issues not detected on routine semen analysis: DNA fragmentation, in particular.
• Protocol mismatch: wrong stim protocol for the patient's ovarian profile.
• Egg-sperm interaction issues: detected only after the cycle fails.
• Laboratory or technical factors: less common but real.

What is not on this evidence-based list, despite frequent search results: caffeine, the wrong yoga pose, sex during the luteal phase, stress in itself (Boivin's meta-analysis found that pre-cycle emotional distress does not, on its own, reduce IVF outcomes).⁷,⁷ The cycle did not fail because of anything you did or did not do in the days before or after the transfer. This is true, even if the internet will try to convince you otherwise.

Depression after failed IVF

I want to name this directly because it is undertreated. Search volume around "depression after failed IVF" is high, and the clinical literature is consistent: the rate of clinically significant depressive symptoms after one or more failed IVF cycles is meaningfully elevated compared to general-population rates. Domar and colleagues' work on IVF dropout showed that emotional distress is one of the most cited reasons patients leave treatment, even when continuing treatment would otherwise be reasonable.⁷ The point is not that depression is causing the failure. It is that depression is a consequence of the failure that, untreated, changes what comes next.

If you are in this category, the right next step is a fertility-aware mental health professional. Many clinics now have one on staff or on referral. A few sessions during the post-cycle window often changes the trajectory. This is not a failure of resilience. It is appropriate care for what is, in clinical literature, recognised as a high-stakes life event.⁷

Questions to bring to the follow-up consult

I recommend writing these out and bringing the list.

1. "Which step in this cycle underperformed compared to expected for my age and AMH?" Specific step, not vague answer.
2. "What specifically would change in cycle 2 protocol, and why?" Not "we'll see how the next baseline looks." A real proposed plan.
3. "What is your honest per-cycle live-birth estimate for me at this point?" Ranges are fine. Vague reassurance is not.
4. "When would you recommend stopping or moving to donor egg or sperm?" Get the answer in the chart now, when the conversation can be calm.
5. "Is recurrent implantation failure a working diagnosis for me? What workup does that trigger?" If you have had two failed euploid transfers, this is the right question.
6. "Are there tests you would order if cost were not a constraint?" Pushes the RE past insurance constraints, and surfaces evidence-weak proposals as well as evidence-supported ones.
7. "Is a second opinion reasonable at this point?" A good RE will say yes.

The universal post-cycle question framework, applicable to letrozole, IUI, and IVF alike, lives in Questions to ask your RE after any failed cycle.

What you can do tonight

Not research. Not optimisation. Not a long read through the cycle summary at 11 pm.

If you need a task, gather the cycle documents in one folder: the stim chart, the fertilisation report, the embryology summary, the transfer note, any beta values, the pathology report if applicable. The consult is easier when the documents are in front of both of you.

Allow the partner to be in their own grief on their own clock. Grief asymmetry between couples after a failed IVF cycle is one of the most common patterns I see in clinic. It is not a relationship problem. It is two people processing the same loss differently. The repair work happens later.

If finances are now a real factor, name that out loud. It is not a failing. It is data. Many couples after a failed IVF cycle find that the financial conversation is harder than the medical one. Naming it removes its hidden weight.

When to call sooner than the planned follow-up

• Heavy bleeding, severe pain, or signs of OHSS post-retrieval (rapid weight gain, abdominal distension, shortness of breath)
• Persistent positive test with bleeding (rule out ectopic; IVF carries a small but real ectopic risk)
• Severe one-sided pelvic pain at any time
• A mental health crisis. Tell someone. Your clinic can refer to a fertility-aware counselor, and many do so the same day.

If you are at 2 failed IVF attempts, what next is rarely a single answer. For most couples it is a tighter protocol, an honest cumulative-rate conversation, and a clear-eyed look at whether a different path now belongs in the picture.

What's next

• If continuing IVF with a protocol change: IVF cycle 2, protocol changes
• If moving to donor egg, donor sperm, or considering adoption: Changing direction after IVF
• If pausing: When to pause TTC
• If recurrent loss is part of the picture: Recurrent loss workup tests
• If you need to sit with the loss first: What you're allowed to feel after a failed cycle
• For the universal question framework: Questions to ask your RE after any failed cycle

Sources

1. Smith ADAC, Tilling K, Nelson SM, Lawlor DA. Live-birth rate associated with repeat in vitro fertilization treatment cycles. JAMA 2015;314(24):2654-2662. Link
2. ESHRE Working Group on Recurrent Implantation Failure. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open 2023;2023(3):hoad023. Link
3. Munné S, Kaplan B, Frattarelli JL, et al. (STAR Study Group). Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertil Steril 2019;112(6):1071-1079. Link
4. Human Fertilisation and Embryology Authority. Fertility treatment 2021: preliminary trends and figures. HFEA, 2023. Link
5. Centers for Disease Control and Prevention. ART National Summary Report (SART/CDC). Link
6. Cozzolino M, Diaz-Gimeno P, Pellicer A, Garrido N. Evaluation of the endometrial receptivity assay and the preimplantation genetic test for aneuploidy in overcoming recurrent implantation failure. J Assist Reprod Genet 2020;37(12):2989-2997. Link
7. Practice Committee of the American Society for Reproductive Medicine. The use of preimplantation genetic testing for aneuploidy: a committee opinion. Fertil Steril 2018;109(3):429-436. Link